Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Frost & Sullivan Recognizes Caradigm as a Product Leader for its Value-based Care Management IT Solutions


SANTA CLARA, Calif., Dec. 12, 2017 /CNW/ -- Based on its analysis of the Healthcare IT ? Value-based Care Management Industry, Frost & Sullivan recognizes Caradigm with the 2017 North America Product Leadership Award for its comprehensive portfolio of healthcare IT solutions that promote data interoperability and evidence-based population health management. Population Health Management (PHM) solutions aggregate data for a specific group of people, often at-risk individuals, across various IT resources into a single record, allowing healthcare providers to analyze that data to improve patient outcomes and reduce medical costs through provisioning of value-based care (VBC). Caradigm, a GE Healthcare company, is a healthcare analytics and population health company headquartered in Bellevue, Washington.

Click here for the full multimedia experience of this release - http://bit.ly/2C3UAML

Historically, the US healthcare system has largely focused on treating patients with immediate needs. In most cases, the market has failed to manage at-risk patients successfully, driving the need for a broader, more coordinated, and patient-specific healthcare ecosystem that can improve prediction and management of population health, especially chronic patient groups. In addition, as healthcare payment models shift away from fee-for-service (FFS)/volume models to outcomes-based systems that advocate accountable care, the need to improve how patients are tracked and coordinated across various care settings is emerging as one of the critical needs in an era of value-based, accountable care.

"Our independent analysis of value-based care management shows that around half of all US-based providers are interested in value-based care initiatives, but don't effectively coordinate care between in-patient, out-patient, and long-term care settings," said Koustav Chatterjee, Industry Analyst with Frost & Sullivan's Digital Health Practice. "Providers also struggle to benchmark patient risk profiles in real time, and fail to develop customized health plans that complement each patient's care expectation."

Caradigm offers a robust VBC management solution portfolio designed to help healthcare providers identify and stratify patient populations eligible for value-based care. Provider-specific care management workflow is supported by a range of next-generation healthcare IT solutions that successfully capture and assess multiple factors, including clinical, financial, behavioral, and social, in real time to assign an evidence-based risk score to each patient undergoing treatment. The company takes a multi-disciplinary approach to product development, offering value-added solutions, such as:

"Caradigm's solutions are part of an integrated software suite that allows for seamless interoperability with its care management platform," said Chatterjee. "The utility of its solutions allows providers to generate actionable intervention strategies at the point-of-service in real time, based on the accurate assessment of each patient's unique clinical requirements and financial risk."

Frost & Sullivan, as a growth partner of leading healthcare stakeholders worldwide, is confident that Caradigm is poised to remain a leading care management vendor for the North American healthcare market through its engagement with integrated delivery networks, community hospitals, and large physician groups that need to comply with challenging VBC criteria. For these reasons, Caradigm has earned Frost & Sullivan's 2017 North America Product Leadership Award.

Each year, Frost & Sullivan presents this award to the company that has developed a product with innovative features and functionality that is gaining rapid market acceptance. The award recognizes the quality of the solution and the customer value enhancements it enables.

Frost & Sullivan Best Practices awards recognize companies in a variety of regional and markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research to identify best practices in the industry.

About Caradigm

Caradigm is a GE Healthcare Company offering intelligent healthcare analytics and population health management solutions. Caradigm is dedicated to improving patient care, advancing the health of populations and reducing healthcare costs. Its enterprise software portfolio encompasses all capabilities critical to delivering effective population health management, including data control; healthcare analytics; and care coordination and engagement. Caradigm's customers include large integrated delivery networks, accountable care organizations, clinically integrated networks, academic medical centers, and community hospital networks. Based in Bellevue, WA, Caradigm received the Frost & Sullivan 2017 North American Health IT Value-Based Care Management Product Leadership Award.To learn more, go to www.caradigm.com

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion.

Contact:
Andrea Steinman
P: 210.477.8425
F: 210.348.1003
E: [email protected]

 

SOURCE Frost & Sullivan


These press releases may also interest you

at 09:41
Hyundai Bioscience announced on April 25th that, after multiple consultations with global clinical research organizations (CRO), it has decided to conduct clinical trials for its 'niclosamide-based Dengue antiviral' in...

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...

at 09:30
PossibleNOWtm, the leading provider of enterprise consent and preference management solutions, today announced the launch of a program to enable companies to quickly capture express written consent. This will provide the ability for Third-Party...

at 09:30
Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study...

at 09:30
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the...

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...



News published on and distributed by: